Meridia medication

The steady-state pharmacokinetics of sibutramine and metabolites M1 and M2 were evaluated in 12 uncomplicated obese subjects following concomitant administration of 500 mg of erythromycin three times daily and 20 mg of sibutramine once daily for 7 days. At that time, the drug was shown to increase heart rate and blood pressure. CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The possible occurrence of cardiac valve disease was specifically investigated in two studies. Properly discard this product when it is expired or no longer needed. Observational epidemiologic studies have established a relationship between obesity and the risks for cardiovascular disease, non-insulin dependent diabetes mellitus (NIDDM), certain forms of cancer, gallstones, certain respiratory disorders, and an increase in overall mortality


Keep your MERIDIA (sibutramine hydrochloride monohydrate) in a safe place to protect it from theft. Read this Medication Guide before you start taking MERIDIA and. Sibutramine is rapidly absorbed from the GI tract (Tmax of 1. 1 h) to form the pharmacologically active mono- and di-desmethyl metabolites M1 and M2. Similarly, there should be at least a 2-week interval after stopping Meridia before starting treatment with MAOIs. , phenelzine, selegiline) in combination with serotonergic agents (e. Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English. Tell your doctor about all medications you use

Droga sibutramina